NovaBay Pharmaceuticals, Inc. (AMEX: NBY) is on The StockGuru Leader Board today. The stock is up as much as 13.93% on Wednesday.
Volume traded – so far – as this release was issued intraday: 101,572
Join in on the Discussion about NBY: http://members.stockguru.com/stocks/nby/
About the Company:
NovaBay Pharmaceuticals Inc., a clinical stage biotechnology company, engages in developing proprietary and patented topical Aganocide compounds for the treatment and prevention of various infections without causing bacterial resistance. Its Aganocide compounds are synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells. The company is developing commercial opportunities for its portfolio of anti-infective Aganocide compounds in four healthcare markets, including dermatology, ophthalmology, urology, and hospital infections. Its lead product candidate, NVC-422, is used for the treatment of adenoviral conjunctivitis, a type of Pink Eye; killing of P. acne, the bacterium associated with inflamed acne lesions, and other known dermal pathogens; and treatment of uropathogens, including Proteus mirabilis, a gram-negative bacterium that can cause urinary catheter blockage and encrustation. The company is also developing NVC-101, an acidic composition of hypochlorous acid to promote wound healing, tissue repair, and tissue regeneration. NovaBay Pharmaceuticals has a licensing and research collaboration agreement with Alcon Manufacturing Ltd. for use of its Aganocide compounds in the eye, ear, and sinus infections, as well as for contact lens solutions; and with Galderma S.A. to develop and commercialize its Aganocide compounds in acne, impetigo, and other dermatological indications. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals was incorporated in 2000 and is based in Emeryville, California.
About the StockGuru Leader Board:
We watch for stocks moving up and creating a positive momentum in the market. We are not compensated for coverage.
Feel free to suggest a stock for coverage if you see it breaking out. Contact: [email protected].
StockGuru.com
StockGuruCanada.com
Shareholdervision.com
BoldStocks.com
IR Affiliates – IRIR.co
StoneBridge Web & SEO – StonebridgeIQ.com
All content on StockGuru.com is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: [email protected] or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070